4.7 Article

PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 290, Issue 1-2, Pages 137-144

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2004.11.027

Keywords

nanoparticles; controlled release; PLGA; praziquantel; emulsification evaporation method

Ask authors/readers for more resources

Praziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticulate drug carriers made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed. Praziquantel, a hydrophobic molecule, was entrapped into the nanoparticles with theoretical loading varying from 10 to 30% (w/w). This investigates the effects of some process variables on the size distribution of nanoparticles prepared by emulsion-solvent evaporation method. The results show that sonication time, PLGA and drug amounts, PVA concentration, ratio between aqueous and organic phases, and the method of solvent evaporation have a significant influence on size distribution of the nanoparticles. (C) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available